Top Stories
A smart phone on a desk with Anthropic's Claude logo on the screen

Anthropic confidentially files for IPO: Here's what it means

Anthropic announced today that it had " confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed initial public offering of our common stock." An S-1 is the registration document a company files with regulators before it

A picture inside an empty theatre in Netflix's Tokyo office with Netflix logo on the screen

Netflix Stock Price Soars After Earnings Report Record New Memberships

Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the

Latest News

Apptly Announces $1,000,000 Non-Brokered Private Placement

Newsfile

Vancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) (the "Company") is pleased to announce that it intends to complete a non-brokered private placement of up to 8,000,000 units of

LevelJump Announces Q2 Record Revenue

Newsfile

Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the second quarter ended June 30, 2026.The Company, through its CTS and AD

BetterLife Pharma Inc. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

Newsfile

PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICESVancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - BetterLife Pharma Inc. (CSE: BETR) ("Bett

AD

Precipitate Grants Incentive Stock Options

Newsfile

Vancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - Precipitate Gold Corp. (TSXV: PRG) (OTCQB: PREIF) (the "Company" or "Precipitate") announces that it has granted an aggregate of 10,170,000 incentive stock options (the "Options") to c

1844 Resources Announces Extension of Non-Brokered Private Placement

Newsfile

Saskatoon, Saskatchewan--(Newsfile Corp. - August 24, 2026) - 1844 Resources Inc. (TSXV: EFF) (the "Company" or "1844") announces that, subject to the approval of the TSX Venture Exchange (the "Exchange"), it has extended the closing date of its prev

ICEsoft Releases Q2 2026 Financial Results

Newsfile

Calgary, Alberta--(Newsfile Corp. - August 24, 2026) - ICEsoft Technologies Canada Corp. (CSE: ISFT) (the "Corporation" or the "Company" or "ICEsoft") is pleased to announce its interim, unaudited financial results for the periods ending June 30, 202

Tethys Petroleum Press Release (TPL): Interim Results and Corporate Update

Newsfile

Grand Cayman, Cayman Islands--(Newsfile Corp. - August 24, 2026) - Tethys Petroleum Limited (TSXV: TPL) ("Tethys" or the "Company") today announced that it has filed its interim results for the three months ended June 30, 2026 with the Canadian secur

SATO Technologies Corp. Announces Loan Settlement Eliminating All of Its Senior Secured Debt and C$1.5 Million Private Placement

Newsfile

Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - SATO Technologies Corp. (TSXV: SATO) ("SATO" or the "Company") is pleased to announce a non-brokered private placement (the "Offering") for aggregate gross proceeds of up to C$1,500,000, consisti

Stria Receives Conditional Approval on Change of Business Transaction

Newsfile

Ottawa, Ontario--(Newsfile Corp. - August 24, 2026) - Stria Lithium Inc. (TSXV: SRA) ("Stria" or the "Company") is pleased to announce that it has received conditional approval from the TSX Venture Exchange (the "Exhange"), pursuant to Policy 5.2 - C

Theralase(R) Closes C$3.6 Million Brokered Financing

Newsfile

Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated smal

AD